Long term (current) use of topoisomerase inhibitor

This code indicates a patient's ongoing, current use of a topoisomerase inhibitor medication for an extended period. These drugs are primarily used in cancer treatment to interfere with DNA replication and repair, thereby inhibiting tumor growth. The "long term" aspect signifies that this is not an acute or short-term prescription.

Apply this code when documenting a patient's active and continuous use of a topoisomerase inhibitor as part of their treatment regimen, typically for various cancers. This code is used to capture the patient's medication history and current therapeutic status, which can impact other medical decisions and care.

• Always sequence this code after the code for the underlying condition being treated by the topoisomerase inhibitor.
• Ensure documentation specifies "long term" or "current" use to differentiate from past or discontinued use.
• Verify the specific drug is a topoisomerase inhibitor (e.g., irinotecan, topotecan, etoposide) to ensure accurate code assignment.